Compounds > 1,4-phenylenebis(methylene)selenocyanate
Page last updated: 2024-11-05

1,4-phenylenebis(methylene)selenocyanate and Cancer of Prostate

1,4-phenylenebis(methylene)selenocyanate has been researched along with Cancer of Prostate in 2 studies

1,4-phenylenebis(methylene)selenocyanate: structure given in first source; inhibits DMBA-induced carcinogenesis by inhibiting DMBA-DNA adduct formation

Research Excerpts

ExcerptRelevanceReference
"The long latency of prostate cancer development provides an opportunity to intervene with agents of known mechanisms at various stages of disease progression."1.361,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells. ( El-Bayoumy, K; Facompre, ND; Pinto, JT; Sinha, R; Sun, YW, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Facompre, ND2
El-Bayoumy, K2
Sun, YW1
Pinto, JT2
Sinha, R2
Sinha, I1

Other Studies

2 other studies available for 1,4-phenylenebis(methylene)selenocyanate and Cancer of Prostate

ArticleYear
1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells.
    Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:8

    Topics: Androgen Antagonists; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Evaluation, Preclin

2010
Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells.
    International journal of cancer, 2012, Nov-01, Volume: 131, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carrier Proteins; Cell Line, Tumor; Cell Proliferati

2012